Perceptions About Asymptomatic Hyperuricemia and Views About Urate‐Lowering Therapy in People With Asymptomatic Hyperuricemia

Documenti analoghi

• Baseline Dual‐Energy Computed Tomography Urate Volume Predicts Fulfillment of Gout Remission After Two Years of Urate‐Lowering Therapy
  di: Adwoa Dansoa Tabi‐Amponsah, et al.
  Pubblicazione: (2024)
• Predicting Gout Flares in People Starting Allopurinol Using the Start‐Low Go‐Slow Dose Escalation Strategy
  di: Lisa K. Stamp, et al.
  Pubblicazione: (2024)
• Hyperuricemia Subtypes Classified According to Renal Uric Acid Handling Manifesting Distinct Phenotypic and Genetic Profiles in People With Gout
  di: Han Qi, et al.
  Pubblicazione: (2024)
• Revisiting the Ethics of Urate‐Lowering Therapy Clinical Trials for Gout Management
  di: Lisa K. Stamp, et al.
  Pubblicazione: (2026)
• Superiority of Low‐Dose Benzbromarone Add‐On to Low‐Dose Febuxostat Compared With Febuxostat Monotherapy in Gout With Combined‐Type Hyperuricemia
  di: Xiaomei Xue, et al.
  Pubblicazione: (2024)